A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multiple Sclerosis

Is this Study for You?

Let's Get Started!



Type of Study



Brain Imaging Center (BIC)
Outpatient CTRC

Principal Investigator
Photograph of Enrique Alvarez,  MD, PhD

Enrique Alvarez, MD, PhD

Study ID

Protocol Number: 22-2421

More information available at ClinicalTrials.gov: NCT05798520

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers